LONG TERM BEHAVIOURAL OUTCOMES FOLLOWING REPEATED DOSES OF UMBILICAL CORD BLOOD CELLS FOR PERINATAL BRAIN INJURY
Background: Hypoxic ischemic (HI) insults during pregnancy and birth can result in long term neurodevelopmental disorders, such as cerebral palsy. This study explored the potential of human umbilical cord blood (hUCB) cells as a treatment for HI brain injury, and specifically aimed to assess if hUCB cells could reduce short and long term behavioural deficits and neuropathology. We also examined the effect of repeated doses of hUCB and different administration routes.
Methods: HI injury was induced in postnatal day (PND) 10 rats by left carotid artery ligation, followed by 90 min of hypoxia (8% oxygen). 24 h later, pups were administered 1 million hUCB cells via either intranasal or intraperitoneal route and received 1 dose (on PND11), or 3 doses (on PND11, 13 & 20) . Rats were monitored until PND50; throughout this period, they underwent extensive behavioural testing. On PND50, brains were collected for immunohistological analysis.
Results: Preliminary results show a trend towards a decrease in brain weight following injury, and treatment with multiple doses of hUCB cells intranasally appears to restore brain weight. Behavioural testing shows a trend towards reduced short-term memory following HI, and this deficit is ameliorated following treatment with hUCB. In addition, repeated doses appear more effective at restoring short-term memory, compared to a single dose, regardless of delivery route.
Conclusions: HI at PND10 results in brain injury and deficits in short-term memory. Treatment with repeated doses of hUCB cells intranasally is more effective than a single dose for reducing tissue damage and restoring short term memory deficits. Background: Breastfeeding is important to the health of very preterm infants, yet this group has a shorter breastfeeding duration. In hospital, bottle feeds may be given when the breastfeeding mother is not available. Use of a vacuum-release teat (Medela Calmita) requires sucking actions similar to breastfeeding and so may promote feeding skills. We compared the effects of vacuum release and standard teat use on achievement of feeding outcomes to 3 months CGA.
USE OF A VACUUM RELEASE TEAT IS ASSOCIATED
Methods: An RCT was conducted with infants born <33/40 randomised to the Calmita group (n=26) or standard group (n=29). PMA at achievement of full oral feeds, and breastfeeding outcomes at 2 weeks, 6 weeks and 3 months CGA were recorded.
Results: PMA at achievement of full oral feeds did not differ between Calmita and standard groups (36.7AE1.04 vs 36.6AE0.94, p=0.95, respectively). The Calmita group had a higher incidence of breastfeeding at 2, 6 and 12 weeks CGA (p=0.01), with more exclusively breastfed at 2 weeks CGA (57% vs 20%, p=0.002).
Conclusions: Use of a vacuum release teat during the preterm infant's hospital stay is associated with improved breastfeeding outcomes to 12 weeks CGA. The Calmita teat may assist establishment of normal sucking behaviours that support longer term breastfeeding success.
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